Lefamulin

Fidelia Bernice, Pharm.D.
Pediatric Dosing Author: Bethany Sharpless Chalk, Pharm.D., BCPPS

INDICATIONS

FDA

Treatment of community-acquired pneumonia caused by susceptible organisms.
- Streptococcus pneumoniae, methicillin-susceptible Staphylococcus aureus, Haemophilus influenzae,Legionella pneumophila, Mycoplasma pneumoniae, and Chlamydophila pneumoniae.

NON-FDA APPROVED USES

In vitro activity has been demonstrated against methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus faecium, multidrug-resistant Neisseria gonorrhoeae, and Mycoplasma genitalium.

There's more to see -- the rest of this topic is available only to subscribers.

© 2000–2025 Unbound Medicine, Inc. All rights reserved

All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.